BRASARTAN® CTDN

Composition:

Valsartan + Chlorthalidone

Indications:

Treatment of hypertension in patients whose blood pressure is not adequately controlled with monotherapy.

Dosage:

As prescribed by a physician, based on individual patient assessment. Treatment is generally initiated with the lowest-strength formulation, with dose adjustments according to therapeutic response and treatment goals. Dosage may be increased from 80 mg/12.5 mg to 160 mg/12.5 mg or 160 mg/25 mg, as determined by the physician.

Presentation:

• Valsartan 80 mg / Chlorthalidone 12.5 mg, box of 30 film-coated tablets
• Valsartan 160 mg / Chlorthalidone 12.5 mg, box of 30 film-coated tablets
• Valsartan 160 mg / Chlorthalidone 25 mg, box of 30 film-coated tablets

Prescription Only.